Should You Accumulate Sigilon Therapeutics Inc (SGTX) Stock Wednesday Morning?

Wednesday, July 05, 2023 07:00 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Sigilon Therapeutics Inc (SGTX) Stock Wednesday Morning?

Sigilon Therapeutics Inc (SGTX) is lower by Wednesday morning, with the stock losing -6.44% in pre-market trading to 21.05. SGTX's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 116 out of 146 industries, Sigilon Therapeutics Inc ranks higher than 100% of stocks. Sigilon Therapeutics Inc has risen 423.26% over the past month, closing at $4.53 on June 7. During this period of time, the stock fell as low as $3.91 and as high as $28.00. SGTX has an average analyst recommendation of Sell. The company has an average price target of $7.00.

SGTX has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on SGTX!

See Full SGTX Report

Sigilon Therapeutics Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 115 by this metric, SGTX ranks better than 115% of stocks.

Important Dates for Investors in SGTX:

-Sigilon Therapeutics Inc is set to release earnings on 8/3/2023. Over the last 12 months, the company has reported EPS of $-1.14. -We do not have a set dividend date for Sigilon Therapeutics Inc at this time. Click Here To Get The Full Report on Sigilon Therapeutics Inc (SGTX)